Spyre Therapeutics, Inc. logo SYRE - Spyre Therapeutics, Inc.

Price: -- -- | CONSENSUS: Buy DETAILS
STRONG
BUY 0
BUY 12
HOLD 1
SELL 0
STRONG
SELL 0
| PRICE TARGET: $106.92 DETAILS
HIGH: $130.00
LOW: $49.00
MEDIAN: $117.50
CONSENSUS: $106.92
UPSIDE: 21.89%

Profitability Ratios

Ratio Value
GP Margin 0.0%
EBIT Margin 0.0%
EBITDA Margin 0.0%
Operating Margin 0.0%
Pretax Margin 0.0%
Cont. Ops Margin 0.0%
Net Margin 0.0%
Bottom Line Margin 0.0%

Liquidity Ratios

Ratio Value
Current Ratio 13.25
Quick Ratio 13.25
Solvency Ratio -2.322
Cash Ratio 1.46

Valuation Ratios

Ratio Value
Price/Earnings
-16.55
Peers avg: 33.1
PEG Ratio 0.44
Forward PEG 0.44
Price/Book 2.93
Price/Sales 0.00
Price/FCF -12.40
Price/Op Cash Flow -12.40

Debt Ratios

Ratio Value
Debt/Assets 0.0000
Debt/Equity 0.0000
Debt/Capital 0.0000
Long-Term Debt/Capital 0.0000
Financial Leverage 1.09

Cash Flow Ratios

Ratio Value
Working Capital Turnover 0.00
Operating Cash Flow Ratio -2.884
Operating Cash Flow/Sales 0.0%
Free Cash Flow/Operating Cash Flow 100.0%

Coverage Ratios

Ratio Value
Debt Service Coverage 0.00
Interest Coverage 0.0000
Short-Term Operating Cash Flow Coverage 0.00
Operating Cash Flow Coverage 0.00
Capital Expenditure Coverage 0.00
Dividend + Capital Expenditure Coverage 0.00

Dividend Ratios

Ratio Value
Payout Ratio 0.0000%
Dividend Yield 0.0000%
Dividend Yield % 0.0000%
Dividend Per Share 0.0000

Per Share Ratios

Ratio Value
Revenue/Share 0.00
EPS -2.423
Debt/Share 0.0000
Cash/Share 11.81
Book Value/Share 11.17
Tangible BV/Share 11.17
Equity/Share 11.17
Operating Cash Flow/Share -2.642
Capital Expenditure/Share 0.000
FCF/Share -2.642

Other Ratios

Ratio Value
Net Income/Earnings Before Tax 1.000
Earnings Before Tax/EBIT 0.741
Price/Fair Value 2.93
Debt/Market Cap 0.0000
Effective Tax Rate 0.0%
Enterprise Value Multiple -9.60